Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
10.18
-0.22 (-2.12%)
Feb 17, 2026, 3:41 PM EST - Market open
Trevi Therapeutics Market Cap
Trevi Therapeutics has a market cap or net worth of $1.31 billion as of February 17, 2026. Its market cap has increased by 274.54% in one year.
Market Cap
1.31B
Enterprise Value
1.11B
1-Year Change
274.54%
Ranking
Category
Stock Price
$10.18
Market Cap Chart
Since May 7, 2019, Trevi Therapeutics's market cap has increased from $84.99M to $1.31B, an increase of 1,435.94%. That is a compound annual growth rate of 49.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 1.33B | -16.93% |
| Dec 31, 2025 | 1.61B | 336.04% |
| Dec 31, 2024 | 368.19M | 330.28% |
| Dec 29, 2023 | 85.57M | -26.01% |
| Dec 30, 2022 | 115.65M | 472.04% |
| Dec 31, 2021 | 20.22M | -54.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Monte Rosa Therapeutics | 1.42B |
| Zenas BioPharma | 1.42B |
| Novavax | 1.41B |
| Savara | 1.38B |
| Intellia Therapeutics | 1.37B |
| Kodiak Sciences | 1.37B |
| Rapport Therapeutics | 1.33B |
| Immatics | 1.32B |